High-dose ropinirole in advanced Parkinson's disease with severe dyskinesias

Clinical Neuropharmacology
S CristinaClaudio Pacchetti

Abstract

Levodopa (LD) is the gold standard of therapy for Parkinson's disease, but it is commonly associated with motor fluctuations and dyskinesias. Dopamine agonists are often used as adjuncts to LD in an attempt to reduce these complications. In this open-label study the authors investigated the effects of high doses of adjunctive ropinirole in 36 patients with advanced Parkinson's disease and normal cognitive status. The daily dose of ropinirole was increased from 18.4 +/- 3.5 mg to 34.7 +/- 5.5 mg, generally in four separate doses. The daily LD dose was decreased from 734.1 +/- 254.8 mg to 502.8 +/- 228.4 mg. After 12 months 25 patients were still on high doses of ropinirole whereas 11 patients had, after either the emergence of side effects or a worsening of their clinical conditions, decreased or interrupted ropinirole. At 12 months, the daily doses of LD and ropinirole were 489 +/- 243 mg and 34.6 +/- 4.6 mg respectively. There was a significant reduction in the Dyskinesia Rating Scale scores during both ON and OFF periods, indicating a reduction in dyskinesias during ON periods and a reduction in dystonias during OFF periods (p < 0.001). Both the intensity and the hours spent during OFF periods were reduced significantly (p < ...Continue Reading

References

Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Jul 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·C G GoetzE E Dorflinger
Jul 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·G PezzoliE Cossutta
May 1, 1996·Movement Disorders : Official Journal of the Movement Disorder Society·A Facca, J Sanchez-Ramos
Aug 1, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·G T Stebbins, C G Goetz
Dec 16, 1998·Neurology·R P Lisak
Jan 5, 2002·Journal of Neural Transmission·M MüngersdorfH Reichmann

❮ Previous
Next ❯

Citations

Oct 14, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M HorstinkUNKNOWN Movement Disorder Society-European Section
Jan 10, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·O Gershanik, P Jenner
Jan 3, 2013·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J J FerreiraW H Oertel
Jul 16, 2013·Parkinson's Disease·Fabrizio GaspariniBaltazar Gomez-Mancilla
Sep 7, 2013·The International Journal of Neuroscience·Rajeev KumarChristopher Kenney
May 11, 2005·Expert Opinion on Investigational Drugs·Spiros Konitsiotis
Jun 27, 2009·Neurologic Clinics·Mark Stacy
Jul 20, 2005·Brain Research. Brain Research Reviews·Milind Deogaonkar, Thyagarajan Subramanian
Jul 5, 2005·Parkinsonism & Related Disorders·Alexander StorchJohannes Schwarz
Feb 3, 2007·Clinical Neuropharmacology·Martin W I M HorstinkBastiaan R Bloem
Apr 3, 2008·Clinical Neuropharmacology·Mark Stacy, Andrew Galbreath
Sep 11, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Fabrizio StocchiC Warren Olanow
Jan 4, 2006·CNS Drug Reviews·Wolfgang H Jost, Dieter Angersbach
Oct 12, 2010·CNS Drugs·Santiago Perez-Lloret, Olivier Rascol
Dec 22, 2005·Acta Neurologica Scandinavica·P OdinP Schüler
Feb 10, 2006·Expert Review of Neurotherapeutics·Ubaldo Bonuccelli, Nicola Pavese
Oct 18, 2007·Expert Review of Neurotherapeutics·Ubaldo Bonuccelli, Nicola Pavese
Nov 4, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·N V Titova
Jul 17, 2020·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Do-Yeon KimHee-Sun Kim
Jan 1, 2011·International Journal of Medicinal Chemistry·Shin Hisahara, Shun Shimohama

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.